AdvaCare is a different kind of pharmaceutical and healthcare products company. We are an American managed company focusing on the developing world. Working with the highest levels of government and local distributors alike, we aim to not only expand our business scale and scope but also have a special interest in serving the needs of the end consumer that requires our products the most. To this end, we have a presence in 4 continents with an expanding product range to meet the demand of our main markets.


214 Million cases of Malaria worldwide

In 2015,
there were 214 million cases of malaria worldwide. This resulted in an estimated 438,000 deaths that year alone, 90% of which occurred in Africa. With the combined effort of the World Health Association and pharmaceutical industries exporting malaria test kits and anti-malarial medications to hospitals in need, we can help end the epidemic of malaria.

Malaria is a mosquito-borne infectious disease. Once a mosquito is infected, the parasite starts growing in its liver and eventually starts attacking red cells. After 10 to 18 days, the parasites are found in the mosquito’s salivary glands. If an infected mosquito bites a human, the parasite is then transferred from one host to another through the bloodstream. The mosquito is not affected by this disease, so it remains healthy and can transmit malaria to anybody it tries to feed on.

The reason why the majority of the cases occur in Africa is because the species that is most likely to carry the disease originates on the African continent. The mosquitoes in Africa have a longer life span; therefore they have a higher tendency to bite humans instead of animals and the parasite has more time to complete its development inside the mosquito, also contributing to the higher rate of infection in the African regions. Symptoms of malaria replicate those of a bad cold or flu such as fever, chills, headache and vomiting. If it is untreated it becomes remarkably worse resulting in yellow skin, seizures, coma, or death. In Africa, there is an estimated loss of 12 billion dollars a year due to increased healthcare costs, lost ability to work, and negative effects on tourism.

The World Health Organization plans to decrease this epidemic by using insecticide-treated mosquito nets and indoor residual sprays. They also plan to supply more diagnostic testing kits and anti-malarial medicines to detect the malaria disease and treat those infected by it. This has dramatically lowered the amount of deaths caused by malaria, but the number of available treatments doesn’t compare to the amount of cases. There are still about 3.2 billion people across 95 countries that are currently at risk of malaria and hundreds of thousands of deaths from this disease are accounted for each year. This is why malaria test kits and antimalarial medications have become one of the most demanded pharmaceutical supplies.
As of 2015 a vaccine for malaria has not been FDA or WHO approved. With that being said, malaria test kits and antimalarials are the only option in the fight against malaria. These medicines work by suppressing the blood stage of malaria infections, its job is to eliminate the parasite in the hosts’ bloodstream. An estimated 6.2 million malaria deaths have been averted globally since 2001. This medication not only benefits people living in high risk areas, but also helps people who are traveling to these places. Travelers have a greater chance of catching malaria because they’ve never been exposed to the disease before; so their immune system isn’t readily available to defend against the disease yet. These medicines can be taken before, during, or after an infection has occurred; it is used to prevent and cure the malaria disease. According to www.who.int ” Between 2000 and 2015, malaria incidence among populations at risk fell by 37% globally.” The World Health Organization states that the elimination of malaria is achievable in the next 15 years. With the evolving market of medical supplies and the expansion of pharmaceuticals, we will continue to see a decrease of malaria cases.

At AdvaCare Pharma we are eager to assist those in need with our line of malaria test kits and anti-malarial medications that are CE certified and produced according to ISO standards. We are certain our products will be effective and we hope to supply hospitals and pharmacies in high risk areas. Together we can help end the malaria epidemic.

About Us
AdvaCare Pharma manufactures affordable generic drugs that uphold the highest quality standards with GMP, CE, ISO, and USFDA certifications.
Inquire with us today if you are interested in distributing our pharmaceuticals, veterinary products, or medical supplies.

Additional Information

AdvaCare is a leading pharmaceutical and healthcare products company supplying distributors, governments and hospitals around the world.

To inquire more about pharmaceutical manufacturing, production, sales, and exporting from China, India, and our other facility locations, please contact us.

The most common markets for our products include the following countries. Please inquire with us if your country or region is not listed:
  • Africa: Nigeria, Niger, Mali, Ghana, Burkina Faso, Mali, Benin, Togo, Cameroon, Gabon, Angola, Sierra Leone, Liberia, Senegal, Ivory Coast, Guinea, Kenya, Ethiopia, Congo, Mozambique, Zambia, Zimbabwe, Rwanda, Malawi, Central Africa Republic, Somalia, Somaliland, Burundi, Tanzania, Namibia.
  • Asia: China, Vietnam, Philippines, Cambodia, Laos, Myanmar, Bangladesh, India, Afghanistan, Kyrgyzstan, Kazakhstan, Azerbaijan, Uzbekistan, Iran, Iraq, Syria, Yemen.
  • South America: Peru, Ecuador, Bolivia, Columbia, Venezuela, Guatemala, El Salvador, Costa Rica, Panama, Belize, Nicaragua, Hondorus, Cuba, Caribbean.
  • Europe: Slovenia, Croatia, Bosnia, Macedonia, Slovakia, Estonia, Latvia.

Get the Latest PRICE UPDATES delivered direct to your inbox